Stephen Buell has resigned as senior vice president of Kidder,Peabody to join D. Blech & Co. Inc. of New York as seniormanaging director.
Gary Frashier, chief executive officer of Oncogene Science Inc.,has also been elected vice chairman of the Uniondale, N.Y.,company. In addition, Steven Peltzman, chief operating officer,has been named president.
Cytel Corp. of San Diego has promoted Robert Chestnut to vicepresident of immunology from senior director of cellularimmunology, Wendy Johnson to vice president of businessdevelopment and regulatory affairs from senior director, andMichael Kriegler to vice president of research and developmentoperations from senior director of molecular biology.
Sugen Inc. of Redwood City, Calif., named Greg Plowmandirector of molecular biology, James Schilling director ofprotein chemistry, Gerald McMahon director of drug discoveryand Darlene Hayes intellectual property manager. Plowmanwas head of a receptor biology program in the Oncology DrugDiscovery Department at Bristol-Myers Squibb. Schilling wasdirector of the Protein Structure Laboratory and adjunctassociate professor in the Department of Biological Sciences atthe University of California, Davis. McMahon was director ofmolecular oncology at the Sandoz Research Institute and Hayeswas patent attorney for Berlex Biosciences, a division of BerlexLaboratories.
Alpha-Beta Technology Inc. of Worcester, Mass., has appointedPaul Bleicher director of clinical affairs and Parrish Galliherdirector of manufacturing development. Bleicher wasdepartment director of the Early Phase Services Department atParexel International Corp.; Galliher was director of processengineering at Biogen Inc.
(c) 1997 American Health Consultants. All rights reserved.